Results 21 to 30 of about 410,972 (315)

Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer

open access: yesFrontiers in Oncology, 2021
Metastatic colorectal cancer (mCRC) is a common and high-risk malignant tumor. Fruquintinib is a novel small-molecule compound with high selective inhibition of vascular endothelial growth factor (VEGF) receptor (VEGFR) for mCRC for which second-line or ...
Yefei Shu, Song Zheng, Song Zheng
doaj   +1 more source

Exanthema in pediatric dermatology - A confusing galaxy of myriad diseases

open access: yesIndian Journal of Paediatric Dermatology, 2021
In the medical literature, exanthem is the name given to a widespread rash that is usually accompanied by systemic symptoms such as fever, malaise, and headache.
Carlo Gelmetti
doaj   +1 more source

Modified F-Expansion Method Applied to Coupled System of Equation [PDF]

open access: yesJournal of Sciences, Islamic Republic of Iran, 2013
A modified F-expansion method to find the exact traveling wave solutions of  two-component nonlinear partial differential equations (NLPDEs) is discussed. We use this method to construct many new solutions to the nonlinear Whitham-Broer-Kaup system (1+1)-
A. Aasaraai   +2 more
doaj  

Mycoplasma pneumoniae induced rash and mucositis sine rash: a distinct entity of erythema multiforma spectrum

open access: yesJournal of Oral Medicine and Oral Surgery, 2020
Mycoplasma pneumoniae induced rash and mucositis (MIRM) is a distinct entity of erythema multiforma spectrum. Observation: we report a case of a 19-year-old man hospitalised for multiple mucosal eruptions and hyperthermia for three days, in context of a ...
Delarue Maxime   +5 more
doaj   +1 more source

First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer [PDF]

open access: yes, 2013
AIM: To investigate activity, toxicity, and prognostic factors for survival of erlotinib and fixed dose-rate gemcitabine (FDR-Gem) in advanced pancreatic cancer.
Bria, E.   +9 more
core   +1 more source

Designing a Model of Effective Development Factors of E-Government Services in Iranian Ministries [PDF]

open access: yesInternational Journal of Management, Accounting and Economics, 2017
The purpose of this research is to design a model of effective development factors of e-government services in Iranian ministries. The present study tried to explore organizational and external factors in Iranian ministries (ministry of labor and social ...
Hamidreza Kelidbari, Nasim Alizadeh
doaj  

Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration [PDF]

open access: yes, 2020
Background Immune checkpoint inhibitors such as nivolumab and targeted BRAF inhibitors have dramatically altered the treatment outcomes of metastatic melanoma over the past few years. Skin toxicity is the most common adverse event (AE) related to the
Maestro, Alessandra   +3 more
core   +1 more source

Polymorphic erythema associated with mycoplasma pneumoniae

open access: yesThe Pan African Medical Journal, 2020
Male child, 6 and a half years old, followed for psychomotor delay from the age of 2 years with diagnosis of epilepsy put on sodium valproate for 3 years and in the absence of seizure control carbamazepine was added 2 months before admission. The patient
Leila Debono, Naima El Hafidi
doaj   +1 more source

Characterizing driving behavior using automatic visual analysis

open access: yes, 2014
In this work, we present the problem of rash driving detection algorithm using a single wide angle camera sensor, particularly useful in the Indian context.
Haloi, Mrinal, Jayagopi, Dinesh Babu
core   +1 more source

Clinical features of varicella-zoster virus infection [PDF]

open access: yes, 2018
Varicella-zoster virus (VZV) is a pathogenic human herpes virus that causes varicella (chickenpox) as a primary infection, following which it becomes latent in peripheral ganglia.
Gershon, Anne A., Kennedy, Peter G.E.
core   +1 more source

Home - About - Disclaimer - Privacy